Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 3, Pages 558
Publisher
MDPI AG
Online
2022-01-24
DOI
10.3390/cancers14030558
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
- (2021) Petra Langerbeins et al. ACTA HAEMATOLOGICA
- Association between thrombocytopenia and 180-day prognosis of COVID-19 patients in intensive care units: A two-center observational study
- (2021) Yuan Zhu et al. PLoS One
- COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
- (2021) Lindsey Elizabeth Roeker et al. BLOOD
- Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients
- (2021) Lisa Blixt et al. LEUKEMIA
- COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
- (2021) Thomas Chatzikonstantinou et al. LEUKEMIA
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
- (2020) Steven P. Treon et al. BLOOD
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement
- (2020) Susmita Paladugu et al. ANNALS OF INTERNAL MEDICINE
- Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study
- (2020) BARTOSZ PULA et al. ANTICANCER RESEARCH
- Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
- (2020) Antonio Cuneo et al. BLOOD
- Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience
- (2020) Anthony R. Mato et al. BLOOD
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
- (2020) Giuseppe Lippi et al. CLINICA CHIMICA ACTA
- The Outcome of COVID‐19 in Patients with Hematological Malignancy
- (2020) Tugce Nur Yigenoglu et al. JOURNAL OF MEDICAL VIROLOGY
- COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
- (2020) Lydia Scarfò et al. LEUKEMIA
- COVID-19 among fit patients with CLL treated with venetoclax-based combinations
- (2020) Moritz Fürstenau et al. LEUKEMIA
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- (2020) Francesco Passamonti et al. Lancet Haematology
- Thrombocytopenia Is Associated with COVID-19 Severity and Outcome: An Updated Meta-Analysis of 5637 Patients with Multiple Outcomes
- (2020) Xiaolong Zong et al. Labmedicine
- Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
- (2020) Stephanie L. Harrison et al. PLOS MEDICINE
- Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia
- (2020) Marta Masternak et al. Cancer Management and Research
- Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
- (2020) Abi Vijenthira et al. BLOOD
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
- (2018) Michael Hallek et al. BLOOD
- A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia
- (2017) Tamar Tadmor et al. Expert Review of Hematology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started